查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2093368

人工關節重建市場－2026-2032年全球市場預測

Joint Replacement Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人工關節重建市場將成長至 311.3 億美元，複合年成長率為 7.26%。

主要市場統計數據
基準年 2025 190.5億美元
預計年份：2026年 203.7億美元
預測年份 2032 311.3億美元
複合年成長率 (%) 7.26%

人工關節重建執行摘要

人工關節重建（包括髖關節、膝關節、關節重建、關節重建關節重建以及髖關節重新置換）仍然是骨科醫學的核心組成部分，其發展動力主要來自人口老齡化、骨關節炎的流行、創傷相關退化性變、發炎性關節疾病以及人們對行動能力日益成長的期望。世界衛生組織（WHO）將骨關節炎列為老年人殘疾最常見的原因之一，凸顯了整形外科關節重組的臨床重要性。該領域正從傳統的植入選擇轉向“精準整形外科”，在精準骨科中，患者的個體解剖結構、骨骼質量、活動水平、合併症負擔以及復健準備都會影響臨床路徑。檢驗的臨床置換術置換術治療末期關節疾病最有效的方法之一，在適應症明確的情況下，能夠改善疼痛、功能和生活品質。同時，醫療保健系統也強調以價值為導向的醫療服務、降低併發症率、縮短住院時間、最佳化圍手術全期方案以及植入的長期性能。因此，關節重建手術的商業環境面臨兩大挑戰：擴大安全、高品質的人工關節重建手術的覆蓋範圍，同時將數位化規劃、機器人技術、尖端材料、感染控制和治療結果測量整合到常規整形外科實踐中。

人工關節重建手術領域的變革性變化

隨著外科治療模式從「以手術數量為導向的醫院模式」轉向以協作和結果為導向的整形外科系統，關節重建手術領域正經歷著變革性的轉變。早期術後復健方案、術前復健、局部麻醉、血液管理和感染控制措施的結合，有助於縮短住院時間，並且在某些患者中，手術擴大在門診進行。技術進步也正在改變臨床決策。機器人輔助整形外科手術、電腦導航、術前3D規劃、個人化器械和先進的影像技術正被用於改善對線、植入定位、軟組織平衡和可重複性，尤其是在複雜的膝關節和髖關節置換術病例中。植入設計也不斷發展，例如高交聯聚乙烯、多孔金屬表面、無骨水泥固定方案、陶瓷軸承材料、雙動結構和模組化重新置換系統等技術，旨在提高穩定性和耐用性。患者的期望也在發生變化，他們更加重視儘早恢復日常生活、治療結果的透明度、協作決策以及數位化後續觀察。然而，該領域面臨著許多持續的限制因素，包括整形外科和復健人員短缺、醫療資源取得的區域差異、植入帶來的成本壓力、監管、醫療設備可追溯性要求以及健全的上市後監測體系。這些變化迫使產業領導者在創新、臨床證據、成本效益和公平獲取之間尋求平衡。

人工智慧在人工關節重建手術中的累積影響

人工智慧 (AI) 在人工關節重建手術的整個過程中發揮著日益重要的作用，從診斷和術前規劃到術中支持、術後監測以及基於植入的結果分析。 AI 驅動的影像工具可以幫助臨床醫生識別骨關節炎的嚴重程度、骨骼畸形、錯位、植入物鬆動、關節周圍骨折以及需要評估是否需要重新置換手術的併發症。在術前規劃中，研究人員正在探索利用機器學習模型，透過臨床數據、X 光影像數據和患者自述數據來預測植入尺寸、手術複雜程度、再入院風險、住院時間、感染風險和復健需求。在手術室中，AI 與機器人、導航和配備感測器的平台相結合，可以幫助規範工作流程、評估對位情況、評估軟組織平衡並收集數據以持續改進手術效果。術後，可以使用遠端監測工具、穿戴式感測器、數位物理治療平台和患者自述結果 (PRO) 系統來追蹤關節活動範圍、步態恢復、疼痛模式、治療依從性以及併發症的早期預警訊號。當演算法經過臨床檢驗、可解釋、能夠與電子健康記錄互通，並在隱私、網路安全和減少偏見的框架內進行管理時，人工智慧的累積效應最為顯著。對於關節重建的相關人員而言，人工智慧不應被視為外科專家的替代品，而應被視為一種決策支援手段，能夠提高準確性、一致性、操作效率和長期療效評估。

關於人工關節重建手術的關鍵區域見解

亞太地區以日本、韓國、中國和澳洲人口快速老化為特徵，同時印度和整個東南亞地區的骨關節炎負擔日益加重，整形外科基礎設施也不斷擴大。儘管該地區在微創手術、無骨植入、機器人輔助關節重建和醫療旅遊等整形外科治療方面取得了進展，但都市區三級醫療機構和農村醫療系統之間在醫療服務取得方面仍然存在差距。北美地區的特點是手術技術高度成熟，廣泛使用註冊登記和品質指標，積極為符合條件的患者開展門診關節重建，并快速整合機器人系統、數位化規劃和基於價值的報銷模式。拉丁美洲在整形外科專科醫生配備、私營部門投資以及老齡化但活躍的人口對髖關節和膝關節關節重建的需求不斷成長方面取得了進展，但成本效益、報銷方案的差異以及公共醫療部門的等待時間仍然是重要的阻礙因素。在歐洲，關節置換的優點包括完善的關節關節重建登記系統、基於醫療設備法規結構的嚴格醫療設備法規，以及在全民健保或混合醫療體系國家中成熟的臨床路徑。植入可追溯性、重新置換手術監測和衛生技術評估（HTA）在該地區尤其重要。在中東，尤其是在高所得醫療體系中，關節重建能力正透過醫院現代化、專家招聘和整形外科卓越中心的建立而不斷擴大。然而，對於與生活方式相關的肌肉骨骼疾病和糖尿病等圍手術全期風險，仍需對治療流程進行精細最佳化。非洲的情況則極為複雜，關節關節重建主要集中在大型都市區醫院和私立醫療機構。整形外科醫療專業人員密度低、植入成本高、復健服務可及性差、手術基礎設施不足等因素限制了關節置換的廣泛應用。

人工關節重建手術的主要群體分析

在東協地區，醫院容量的擴大、部分國家的醫療旅遊、日益加重的肌肉骨骼疾病負擔以及對價格合理的髖關節和膝關節關節重建需求的成長，都在推動關節重建手術的普及。然而，保險報銷的差異和專科醫師的集中度仍然影響著病患的就醫。在海灣合作理事會（GCC）國家，得益於高額的醫療支出和旨在加強國內專科醫療體系的政策，整形外科服務正透過先進的醫院基礎設施、國際臨床標準以及對關節重建手術和數位醫療的投資而得到提升。歐盟透過協調一致的醫療設備法規、多個成員國的國家假體註冊系統、對上市後臨床隨訪的重視以及將創新與循證醫學和患者療效聯繫起來的醫療技術評估框架，為關節置換手術提供了最為完善的環境之一。金磚國家擁有龐大的患者群體、日益加重的非傳染性疾病負擔、不斷成長的中產階級醫療保健需求以及自主生產的意願，正在為經濟高效的植入、外科培訓和可擴展的關節關節重建途徑創造多元化的機會。七國集團（G7）國家通常擁有成熟的整形外科體系、豐富的臨床研究成果、較高的註冊登記參與率、完善的重新置換手術監測機制，以及先進的機器人技術、導航技術和門診模式，並輔以相應的報銷機制和患者篩選標準。北約成員國與北美和歐洲的先進整形外科市場高度重合，這些地區的軍事和創傷護理經驗、復健基礎設施和採購標準很可能影響整形外科創新，尤其是在複雜重組手術、創傷相關關節重建和肌肉骨骼護理能力方面。

人工關節重建手術的關鍵國家概況

美國展現了先進的關節置換術，積極推行針對特定患者的門診手術，整合機器人技術，借鑒打包關節重建系統的經驗，並利用患者報告結果。加拿大維持著高品質的公共整形外科醫療體系，但擇期髖關節和膝關節關節重建的等待時間仍然是政策關注的重點，該國正在推廣集中式患者入院、優先排序工具和手術效率提升計畫。墨西哥正透過私立醫院、跨境醫療和專科培訓來擴大整形外科服務的覆蓋範圍，但公共部門的容量和成本效益仍然影響著醫療服務的使用率。巴西擁有龐大的整形外科患者群體，主要醫療中心也具備成熟的外科技術，但地區差異和分散的保險公司影響了患者獲得先進植入和重新置換手術的機會。英國透過國家指南、註冊數據和消除擇期手術等待名單的努力，強調循證關節關節重建。德國以其強大的整形外科手術能力、醫院專業化程度高和技術應用而聞名，但也面臨著提高品質透明度和效率的政策壓力。法國將卓越的外科技術與系統的報銷制度和法律規範相結合，從而保障了髖關節和膝關節關節重建手術的廣泛普及。在俄羅斯，由於人口老化、創傷和退化性疾病的增加，對人工關節置換手術的需求不斷成長，但醫療服務的可近性取決於區域醫療投資、採購政策和國內生產優先事項。義大利和西班牙擁有成熟的整形外科體系、龐大的老齡人口以及在公共醫療領域的重要地位，但區域手術能力和等待時間存在差異。在中國，由於人口老化、骨關節炎負擔加重以及醫院現代化，對人工關節重建手術的需求不斷成長，促使人們更加重視國產植入生產、外科醫生培訓和集中採購機制。在印度，儘管關節關節重建手術的需求遠未得到滿足，但私營部門開展的關節置換手術、海外醫療旅遊以及對低成本植入的使用都在不斷增加，然而，農村地區和低收入群體獲得手術的機會仍然有限。日本的特點是擁有先進的整形外科醫療體系，由於預期壽命的延長，關節置換手術的需求量很大，而且人們非常重視植入的耐用性和功能恢復。澳洲受益於基於註冊的品質監測、積極實施循證植入監測以及對關節關節重建效果的高標準。韓國擁有完善的醫院基礎設施，技術應用迅速，由於人口老化和積極的生活方式，對膝關節和髖關節置換術的需求不斷成長。

為人工關節重建行業的領導者提供的實用建議

產業領導者應優先考慮實證創新，將植入設計、機器人技術、導航系統、人工智慧工具和數位化復健平台與整個治療過程中安全性、功能性、耐用性和價值方面的可衡量改進相結合。建立強大的真實世界證據（REW）計畫至關重要，包括參與註冊研究、植入可追溯性、患者報告結果的測量、重新置換追蹤和上市後臨床追蹤。各機構應透過模擬、導師培訓、數據驅動的回饋和新技術標準化培訓來加強外科醫生教育，以減少差異並支持可重複的治療結果。准入策略應根據當地實際情況量身定做，包括提供價格合理的植入產品線、在合適的地點進行本地生產或組裝、資金籌措夥伴關係以及支持公共和私人醫療保健系統的服務模式。在門診和短期住院人工關節重建方面，領導者應投資於病患選擇分析、手術全期最佳化、感染預防、數位化出院計畫和協調的復健路徑。人工智慧專案的管理應基於檢驗的臨床性能、互通性、網路安全、透明的模型監管以及防止人口統計和社會經濟偏見的保障措施。最後，製造商、醫療服務提供者、監管機構、保險公司、臨床醫生和患者團體應通力合作，確保創新得到負責任的實施，並持續以客觀的臨床和功能指標為基準評估人工關節重建手術的療效。

瞭解人工關節重建手術的調查方法

本執行摘要基於系統性的二手研究方法，採用經核實、公開且與臨床相關的資訊來源，包括整形外科協會指南、同行檢驗的醫學文獻、國家關節關節重建研究途徑發布的出版刊物、公共衛生資料集、法規結構、報銷政策文件、醫院品質改進舉措以及醫療技術評估數據。調查方法強調對臨床證據、手術流程趨勢、醫療設備法規、人口統計指標、骨關節炎關節重建、置換術可近性因素以及當地醫療基礎設施檢驗。研究結果評估了其與全髖關節、膝關節、肩關節、踝關節和重新置換關節重建關節重建手術、數位整形外科、機器人輔助手術、植入材料、手術全期護理和復健模式的相關性。本分析不涉及市場規模計算、市場預測、市場佔有率計算和未來展望；而是側重於影響策略、應用、可及性和治療結果的定性且基於證據的趨勢。我們特別關注數據的可靠性、及時性和跨區域一致性，以及數據對參與整形外科醫學、醫療技術、醫療保健服務和政策制定的決策者的實際適用性。

結論

關節重建手術正朝著更精準、數據化和注重治療效果的新時代邁進。最大的機會在於將植入創新、外科手術專長、機器人技術、人工智慧、手術全期最佳化和復健整合到一個連貫的診療路徑中，從而在改善患者功能的同時，有效控制併發症和資源消耗。區域和國家間的差異仍然顯著：成熟的醫療體系專注於品質標竿管理、門診路徑和預防重新置換手術，而新興的醫療體系則優先考慮可及性、可負擔性、人才培養和基礎設施建設。人工智慧、真實世界數據和基於註冊登記的監測將日益成為競爭差異化、監管信任和臨床應用的重要驅動力。對於行業領導者而言，策略重點十分明確：提供經臨床檢驗的技術和服務模式，以支持永續的治療效果、公平的醫療服務獲取、外科醫生的信心以及貫穿整個關節重建手術過程的可衡量價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：人工關節重建市場：依關節類型分類

  • 肢體關節
    • 踝關節
    • 彎頭
    • 手腕
  • 髖關節
  • 膝蓋

第8章：人工關節重建市場：依植入材料分類

  • 陶瓷
  • 金屬
    • 鈷
    • 鎳
    • 鈦
    • 鋯
  • 聚乙烯

第9章：人工關節重建市場：以固定方式分類

  • 水泥固定型
  • 無水泥
  • 混合

第10章：人工關節重建市場：依技術類型分類

  • 傳統關節重建手術
  • 電腦輔助手術
  • 機器人輔助手術
  • 患者專用設備

第11章：人工關節重建市場：依應用領域分類

  • 關節炎
  • 缺血性壞死
  • 退化性關節疾病

第12章：人工關節重建市場：依最終用戶分類

  • 門診手術中心
  • 醫院和診所

第13章：人工關節重建市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：人工關節重建市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：人工關節重建市場：依國家分類

  • 美國
  • 中國
  • 德國
  • 印度
  • 日本
  • 加拿大
  • 英國
  • 俄羅斯
  • 巴西
  • 義大利
  • 墨西哥
  • 法國
  • 西班牙
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Acumed LLC
  • AK Medical Holdings Limited
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Beijing Chunlizhengda Medical Instruments Co., Ltd.
  • Conformis, Inc.
  • CONMED Corporation
  • Corin Group
  • Enovis Corporation
  • Exactech, Inc.
  • FH Orthopedics
  • Globus Medical, Inc.
  • Implantcast GmbH
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc
  • LimaCorporate SpA
  • Mathys AG
  • MatOrtho Limited
  • Medacta Group SA
  • Medartis AG
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Orthofix Medical Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • United Orthopedic Corporation
  • Waldemar Link GmbH & Co. KG
  • Zimmer Biomet Holdings, Inc.
  • ZimVie Inc.
Product Code: MRR-C2718791421F

The Joint Replacement Market is projected to grow by USD 31.13 billion at a CAGR of 7.26% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.05 billion
Estimated Year [2026] USD 20.37 billion
Forecast Year [2032] USD 31.13 billion
CAGR (%) 7.26%

Joint Replacement Executive Summary

Joint replacement, including hip replacement, knee replacement, shoulder arthroplasty, ankle replacement, and revision arthroplasty, remains a core pillar of orthopedic care as aging populations, osteoarthritis prevalence, trauma-related degeneration, inflammatory joint disease, and rising expectations for mobility continue to shape procedural demand. The World Health Organization identifies osteoarthritis as one of the most common causes of disability in older adults, reinforcing the clinical importance of durable joint reconstruction. The field is moving beyond conventional implant selection toward precision orthopedics, where patient-specific anatomy, bone quality, activity level, comorbidity burden, and rehabilitation readiness influence clinical pathways. Verified clinical evidence consistently shows that total hip and total knee arthroplasty are among the most effective interventions for end-stage joint disease, improving pain, function, and quality of life when appropriately indicated. At the same time, health systems are emphasizing value-based care, lower complication rates, shorter length of stay, optimized perioperative protocols, and durable implant performance. The executive landscape for joint replacement is therefore defined by a dual imperative: expanding access to safe, high-quality arthroplasty while integrating digital planning, robotics, advanced materials, infection prevention, and outcomes measurement into routine orthopedic practice.

Transformative Shifts in the Joint Replacement Landscape

The joint replacement landscape is undergoing transformative change as surgical care shifts from volume-driven hospital models to coordinated, outcomes-focused orthopedic ecosystems. Enhanced recovery after surgery protocols, prehabilitation, regional anesthesia, blood management, and infection prevention bundles have supported shorter hospital stays and, in selected patients, migration of procedures to ambulatory surgical settings. Technology adoption is also reshaping clinical decision-making. Robotic-assisted orthopedic surgery, computer navigation, 3D preoperative planning, patient-specific instrumentation, and advanced imaging are being used to improve alignment, implant positioning, soft-tissue balancing, and reproducibility, particularly in complex knee and hip arthroplasty cases. Implant design continues to evolve through highly cross-linked polyethylene, porous metal surfaces, cementless fixation options, ceramic bearing materials, dual-mobility constructs, and modular revision systems intended to improve stability and longevity. Patient expectations are also changing, with greater emphasis on rapid return to daily activities, transparent outcomes, shared decision-making, and digital follow-up. However, the sector faces persistent constraints, including workforce shortages in orthopedic surgery and rehabilitation, uneven access across regions, implant cost pressures, regulatory scrutiny, device traceability requirements, and the need for robust post-market surveillance. These shifts are compelling industry leaders to balance innovation with clinical evidence, cost-effectiveness, and equitable access.

Cumulative Impact of Artificial Intelligence on Joint Replacement

Artificial intelligence is becoming an increasingly important enabler across the joint replacement continuum, from diagnosis and surgical planning to intraoperative support, postoperative monitoring, and registry-based outcomes analysis. AI-enabled imaging tools can assist clinicians in identifying osteoarthritis severity, bone deformity, alignment abnormalities, implant loosening, periprosthetic fracture, and complications that require revision evaluation. In preoperative planning, machine learning models are being explored to predict implant sizing, surgical complexity, readmission risk, length of stay, infection risk, and rehabilitation needs using clinical, radiographic, and patient-reported data. In operating rooms, AI integrated with robotics, navigation, and sensor-enabled platforms can support workflow standardization, alignment assessment, soft-tissue balance evaluation, and data capture for continuous improvement. Postoperatively, remote monitoring tools, wearable sensors, digital physical therapy platforms, and patient-reported outcome systems can help track range of motion, gait recovery, pain patterns, adherence, and early warning signs of complications. The cumulative impact of AI is strongest when algorithms are clinically validated, explainable, interoperable with electronic health records, and governed by privacy, cybersecurity, and bias-mitigation frameworks. For joint replacement stakeholders, AI should be viewed not as a replacement for surgical expertise but as a decision-support layer that can enhance precision, consistency, operational efficiency, and longitudinal outcomes measurement.

Key Regional Insights for Joint Replacement

Asia-Pacific is shaped by rapidly aging populations in Japan, South Korea, China, and Australia, along with a growing burden of osteoarthritis and expanding orthopedic infrastructure across India and Southeast Asia. The region shows increasing adoption of minimally invasive techniques, cementless implants, robotic-assisted joint replacement, and medical tourism-linked orthopedic care, although access remains uneven between urban tertiary centers and rural health systems. North America is characterized by high procedural maturity, broad use of registries and quality metrics, strong adoption of outpatient arthroplasty for appropriate patients, and accelerated integration of robotic systems, digital planning, and value-based reimbursement models. Latin America is advancing through improving specialist availability, private-sector orthopedic investment, and demand for hip and knee replacement among aging and active populations, while affordability, reimbursement variability, and public-sector waiting times remain important constraints. Europe benefits from established arthroplasty registries, strict device regulation under medical device frameworks, and mature clinical pathways in countries with universal or mixed healthcare systems; the region places strong emphasis on implant traceability, revision surveillance, and health technology assessment. The Middle East is expanding joint replacement capabilities through hospital modernization, specialist recruitment, and orthopedic centers of excellence, particularly in higher-income health systems, while lifestyle-related musculoskeletal disease and diabetes-related perioperative risk require careful pathway optimization. Africa presents a highly heterogeneous environment where joint replacement access is concentrated in major urban hospitals and private facilities, with broader adoption constrained by limited orthopedic workforce density, implant affordability, rehabilitation access, and surgical infrastructure.

Key Group Insights for Joint Replacement

Within ASEAN, joint replacement adoption is influenced by expanding hospital capacity, medical tourism in selected countries, rising musculoskeletal disease burden, and increasing demand for affordable hip and knee arthroplasty, though reimbursement disparities and specialist concentration continue to affect access. GCC countries are strengthening orthopedic services through advanced hospital infrastructure, international clinical standards, and investment in robotic surgery and digital health, supported by high healthcare spending and policy focus on domestic specialty care capacity. The European Union provides one of the most structured environments for joint replacement through coordinated medical device regulation, national arthroplasty registries in several member states, emphasis on post-market clinical follow-up, and health technology assessment frameworks that link innovation to evidence and patient outcomes. BRICS economies combine large patient populations, rising noncommunicable disease burdens, expanding middle-class healthcare demand, and domestic manufacturing ambitions, creating diverse opportunities for cost-effective implants, surgeon training, and scalable arthroplasty pathways. G7 countries generally exhibit mature orthopedic systems with strong clinical research output, registry participation, revision monitoring, and advanced adoption of robotics, navigation, and outpatient care models where supported by reimbursement and patient selection criteria. NATO member countries overlap significantly with advanced orthopedic markets in North America and Europe, where military and trauma care experience, rehabilitation infrastructure, and procurement standards can influence orthopedic innovation, particularly for complex reconstruction, trauma-related arthroplasty, and musculoskeletal readiness.

Key Country Insights for Joint Replacement

The United States demonstrates advanced joint replacement capacity, with high use of total knee and hip arthroplasty, strong ambulatory surgery adoption for selected patients, and growing integration of robotics, bundled payment lessons, and patient-reported outcomes. Canada maintains a publicly funded orthopedic environment where quality standards are high, but wait times for elective hip and knee replacement remain a policy focus, encouraging centralized intake, prioritization tools, and surgical efficiency programs. Mexico is expanding orthopedic access through private hospitals, cross-border care, and specialist development, while public-sector capacity and affordability continue to shape utilization. Brazil has a large orthopedic patient base and established surgical expertise in major centers, but regional inequality and payer fragmentation affect access to advanced implants and revision services. The United Kingdom emphasizes evidence-based arthroplasty through national guidance, registry data, and efforts to address elective surgery backlogs. Germany is recognized for high orthopedic procedure capacity, hospital specialization, and technical adoption, while also facing policy pressure to improve quality transparency and efficiency. France combines strong surgical expertise with structured reimbursement and regulatory oversight, supporting broad access to hip and knee replacement. Russia presents demand driven by aging, trauma, and degenerative disease, with access influenced by regional health investment, procurement policy, and domestic production priorities. Italy and Spain have mature orthopedic systems, substantial aging populations, and strong public healthcare roles, though regional capacity and waiting times can vary. China is experiencing rising arthroplasty demand due to demographic aging, osteoarthritis burden, and hospital modernization, with increasing focus on domestic implant production, surgeon training, and centralized procurement mechanisms. India combines significant unmet need with expanding private-sector arthroplasty, medical value travel, and growing use of cost-sensitive implants, while access remains limited in rural and lower-income populations. Japan has advanced orthopedic capabilities, high longevity-related need, and strong interest in implant durability and functional recovery. Australia benefits from registry-led quality monitoring, strong uptake of evidence-based implant surveillance, and high standards for arthroplasty outcomes. South Korea has sophisticated hospital infrastructure, rapid technology adoption, and growing demand for knee and hip replacement linked to aging and active lifestyles.

Actionable Recommendations for Joint Replacement Industry Leaders

Industry leaders should prioritize evidence-driven innovation by aligning implant design, robotics, navigation, AI tools, and digital rehabilitation platforms with measurable improvements in safety, function, durability, and total episode-of-care value. Building robust real-world evidence programs is essential, including registry participation, implant traceability, patient-reported outcome measurement, revision tracking, and post-market clinical follow-up. Organizations should strengthen surgeon education through simulation, proctoring, data-enabled feedback, and standardized training for new technologies to reduce variability and support reproducible outcomes. Access strategies should be tailored to regional realities, including affordable implant portfolios, local manufacturing or assembly where appropriate, financing partnerships, and service models that support public and private healthcare systems. In ambulatory and short-stay arthroplasty, leaders should invest in patient selection analytics, perioperative optimization, infection prevention, digital discharge planning, and coordinated rehabilitation pathways. AI initiatives should be governed by validated clinical performance, interoperability, cybersecurity, transparent model monitoring, and safeguards against demographic or socioeconomic bias. Finally, manufacturers, healthcare providers, regulators, payers, clinicians, and patient groups should collaborate to ensure that innovation is adopted responsibly and that joint replacement outcomes are continuously benchmarked against objective clinical and functional indicators.

Research Methodology for Joint Replacement Insights

This executive summary is built on a structured secondary research approach using verified, publicly accessible, and clinically relevant sources, including orthopedic society guidance, peer-reviewed medical literature, national arthroplasty registry publications, public health datasets, regulatory frameworks, reimbursement policy documents, hospital quality initiatives, and health technology assessment materials. The methodology emphasizes triangulation across clinical evidence, procedural pathway trends, device regulation, demographic indicators, osteoarthritis burden, surgical access factors, and regional healthcare infrastructure. Insights were evaluated for relevance to hip replacement, knee replacement, shoulder arthroplasty, ankle replacement, revision joint replacement, digital orthopedics, robotic-assisted surgery, implant materials, perioperative care, and rehabilitation models. The analysis excludes market sizing, market estimation, market share calculations, and forecasting, focusing instead on qualitative and evidence-backed trends that influence strategy, adoption, access, and outcomes. Particular attention was given to data credibility, recency, consistency across geographies, and practical applicability for decision-makers in orthopedic care, medical technology, healthcare delivery, and policy planning.

Conclusion

Joint replacement is entering a more precise, data-enabled, and outcomes-oriented era. The strongest opportunities are emerging where implant innovation, surgical expertise, robotics, AI, perioperative optimization, and rehabilitation are integrated into coherent care pathways that improve patient function while controlling complications and resource use. Regional and country-level differences remain substantial, with mature systems focusing on quality benchmarking, outpatient pathways, and revision prevention, while emerging systems prioritize access, affordability, workforce development, and infrastructure expansion. Artificial intelligence, real-world evidence, and registry-based surveillance will increasingly shape competitive differentiation, regulatory confidence, and clinical adoption. For industry leaders, the strategic priority is clear: deliver clinically validated technologies and service models that support durable outcomes, equitable access, surgeon confidence, and measurable value across the full joint replacement journey.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Joint Replacement Market, by Joint Type

  • 7.1. Introduction
  • 7.2. Extremity Joint
    • 7.2.1. Ankle
    • 7.2.2. Elbow
    • 7.2.3. Wrist
  • 7.3. Hip
  • 7.4. Knee

8. Joint Replacement Market, by Implant Material

  • 8.1. Introduction
  • 8.2. Ceramics
  • 8.3. Metals
    • 8.3.1. Cobalt
    • 8.3.2. Nickel
    • 8.3.3. Titanium
    • 8.3.4. Zirconium
  • 8.4. Polyethylene

9. Joint Replacement Market, by Fixation Technique

  • 9.1. Introduction
  • 9.2. Cemented
  • 9.3. Cementless
  • 9.4. Hybrid

10. Joint Replacement Market, by Technology Type

  • 10.1. Introduction
  • 10.2. Conventional Joint Replacement
  • 10.3. Computer-Assisted Surgery
  • 10.4. Robotic-Assisted Surgery
  • 10.5. Patient-Specific Instrumentation

11. Joint Replacement Market, by Applications

  • 11.1. Introduction
  • 11.2. Arthritis
  • 11.3. Avascular Necrosis
  • 11.4. Degenerative Joint Diseases

12. Joint Replacement Market, by End Users

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Hospitals & Clinics

13. Joint Replacement Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Joint Replacement Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Joint Replacement Market, by Country

  • 15.1. United States
  • 15.2. China
  • 15.3. Germany
  • 15.4. India
  • 15.5. Japan
  • 15.6. Canada
  • 15.7. United Kingdom
  • 15.8. Russia
  • 15.9. Brazil
  • 15.10. Italy
  • 15.11. Mexico
  • 15.12. France
  • 15.13. Spain
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Acumed LLC
  • 17.2. AK Medical Holdings Limited
  • 17.3. Arthrex, Inc.
  • 17.4. B. Braun Melsungen AG
  • 17.5. Beijing Chunlizhengda Medical Instruments Co., Ltd.
  • 17.6. Conformis, Inc.
  • 17.7. CONMED Corporation
  • 17.8. Corin Group
  • 17.9. Enovis Corporation
  • 17.10. Exactech, Inc.
  • 17.11. FH Orthopedics
  • 17.12. Globus Medical, Inc.
  • 17.13. Implantcast GmbH
  • 17.14. Integra LifeSciences Corporation
  • 17.15. Johnson & Johnson Services, Inc
  • 17.16. LimaCorporate S.p.A.
  • 17.17. Mathys AG
  • 17.18. MatOrtho Limited
  • 17.19. Medacta Group SA
  • 17.20. Medartis AG
  • 17.21. Meril Life Sciences Pvt. Ltd.
  • 17.22. MicroPort Scientific Corporation
  • 17.23. Orthofix Medical Inc.
  • 17.24. Smith & Nephew plc
  • 17.25. Stryker Corporation
  • 17.26. United Orthopedic Corporation
  • 17.27. Waldemar Link GmbH & Co. KG
  • 17.28. Zimmer Biomet Holdings, Inc.
  • 17.29. ZimVie Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL JOINT REPLACEMENT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL JOINT REPLACEMENT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL JOINT REPLACEMENT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL JOINT REPLACEMENT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL JOINT REPLACEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL JOINT REPLACEMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL JOINT REPLACEMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXTREMITY JOINT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTREMITY JOINT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTREMITY JOINT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANKLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANKLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANKLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ELBOW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ELBOW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ELBOW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WRIST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WRIST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WRIST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL KNEE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL KNEE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL KNEE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CERAMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CERAMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CERAMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL METALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL METALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL METALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COBALT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COBALT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COBALT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NICKEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NICKEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NICKEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ZIRCONIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ZIRCONIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ZIRCONIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POLYETHYLENE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POLYETHYLENE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POLYETHYLENE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CEMENTED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CEMENTED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CEMENTED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CEMENTLESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CEMENTLESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CEMENTLESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HYBRID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HYBRID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HYBRID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONVENTIONAL JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONVENTIONAL JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONVENTIONAL JOINT REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COMPUTER-ASSISTED SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COMPUTER-ASSISTED SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COMPUTER-ASSISTED SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC-ASSISTED SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC-ASSISTED SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC-ASSISTED SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PATIENT-SPECIFIC INSTRUMENTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PATIENT-SPECIFIC INSTRUMENTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PATIENT-SPECIFIC INSTRUMENTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ARTHRITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTHRITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ARTHRITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AVASCULAR NECROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AVASCULAR NECROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AVASCULAR NECROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DEGENERATIVE JOINT DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DEGENERATIVE JOINT DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DEGENERATIVE JOINT DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA JOINT REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. GCC JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 152. GCC JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. GCC JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 154. GCC JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 155. GCC JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 157. GCC JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 176. G7 JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. G7 JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 179. G7 JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 180. G7 JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 181. G7 JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 182. G7 JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 184. G7 JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 185. NATO JOINT REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. NATO JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. NATO JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 188. NATO JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. NATO JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 190. NATO JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 191. NATO JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 193. NATO JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL JOINT REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 213. GERMANY JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. GERMANY JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. GERMANY JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 216. GERMANY JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 217. GERMANY JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 218. GERMANY JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 219. GERMANY JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. GERMANY JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 221. GERMANY JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 222. INDIA JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. INDIA JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. INDIA JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 225. INDIA JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 226. INDIA JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 227. INDIA JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 228. INDIA JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. INDIA JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 230. INDIA JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 232. JAPAN JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. JAPAN JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 234. JAPAN JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. JAPAN JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 236. JAPAN JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 237. JAPAN JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. JAPAN JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 239. JAPAN JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 244. CANADA JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED KINGDOM JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED KINGDOM JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED KINGDOM JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED KINGDOM JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED KINGDOM JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED KINGDOM JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED KINGDOM JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED KINGDOM JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED KINGDOM JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 258. RUSSIA JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. RUSSIA JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. RUSSIA JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 261. RUSSIA JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 262. RUSSIA JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 263. RUSSIA JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 264. RUSSIA JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. RUSSIA JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 266. RUSSIA JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 267. BRAZIL JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. BRAZIL JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 275. BRAZIL JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 276. ITALY JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. ITALY JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. ITALY JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 279. ITALY JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 280. ITALY JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 281. ITALY JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 282. ITALY JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. ITALY JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 284. ITALY JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. MEXICO JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. MEXICO JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 288. MEXICO JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 289. MEXICO JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 290. MEXICO JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 291. MEXICO JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 294. FRANCE JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 295. FRANCE JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 303. SPAIN JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. SPAIN JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. SPAIN JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 306. SPAIN JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 307. SPAIN JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 308. SPAIN JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 309. SPAIN JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. SPAIN JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 311. SPAIN JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 312. AUSTRALIA JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. AUSTRALIA JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. AUSTRALIA JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 315. AUSTRALIA JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 316. AUSTRALIA JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 317. AUSTRALIA JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 318. AUSTRALIA JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. AUSTRALIA JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 320. AUSTRALIA JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 321. SOUTH KOREA JOINT REPLACEMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. SOUTH KOREA JOINT REPLACEMENT MARKET SIZE, BY JOINT TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. SOUTH KOREA JOINT REPLACEMENT MARKET SIZE, BY EXTREMITY JOINT, 2018-2032 (USD MILLION)
  • TABLE 324. SOUTH KOREA JOINT REPLACEMENT MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 325. SOUTH KOREA JOINT REPLACEMENT MARKET SIZE, BY METALS, 2018-2032 (USD MILLION)
  • TABLE 326. SOUTH KOREA JOINT REPLACEMENT MARKET SIZE, BY FIXATION TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 327. SOUTH KOREA JOINT REPLACEMENT MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 328. SOUTH KOREA JOINT REPLACEMENT MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 329. SOUTH KOREA JOINT REPLACEMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 330. GLOBAL JOINT REPLACEMENT MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 331. GLOBAL JOINT REPLACEMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025